|
PL207610B1
(pl)
*
|
1999-04-30 |
2011-01-31 |
Pfizer Prod Inc |
Związki modulujące receptory glukokortykoidowe, ich zastosowanie do wytwarzania leku i środek farmaceutyczny
|
|
GB0019172D0
(en)
|
2000-08-05 |
2000-09-27 |
Glaxo Group Ltd |
Novel compounds
|
|
US6777399B2
(en)
|
2000-08-05 |
2004-08-17 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative compositions
|
|
US6858596B2
(en)
|
2000-08-05 |
2005-02-22 |
Smithkline Beecham Corporation |
Formulation containing anti-inflammatory androstane derivative
|
|
CA2417826A1
(en)
|
2000-08-05 |
2002-02-14 |
Glaxo Group Limited |
17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents
|
|
IL146057A
(en)
*
|
2000-10-27 |
2007-09-20 |
Pfizer Prod Inc |
A process for the preparation of modulators of a non-steroidal glucocorticoid receptor
|
|
EP1201649B1
(en)
*
|
2000-10-28 |
2006-05-31 |
Pfizer Products Inc. |
Glucocorticoid receptor modulators
|
|
ES2246292T3
(es)
|
2000-10-30 |
2006-02-16 |
Pfizer Products Inc. |
Moduladores de receptor glucocorticoide.
|
|
AR033290A1
(es)
|
2001-04-30 |
2003-12-10 |
Glaxo Group Ltd |
Derivados antiinflamatorios de androstano
|
|
US8193172B2
(en)
|
2001-11-23 |
2012-06-05 |
Pop Test Cortisol Llc |
Methods for the treatment of major depressive disorder using glucocorticoid receptor antagonists
|
|
WO2003059267A2
(en)
*
|
2001-12-21 |
2003-07-24 |
Rhode Island Hospital |
SELECTIVE 11β-HSD INHIBITORS AND METHODS FOR USE THEREOF
|
|
US20060148725A1
(en)
*
|
2001-12-21 |
2006-07-06 |
The Miriam Hospital |
Selective 11beta HSD inhibitors and methods of use thereof
|
|
EP1467982B8
(en)
|
2002-01-14 |
2007-04-11 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them, and uses thereof
|
|
JP4324480B2
(ja)
*
|
2002-03-26 |
2009-09-02 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
グルココルチコイドミメティクス、その製法、医薬組成物、及び使用
|
|
EP1490317A1
(en)
|
2002-03-26 |
2004-12-29 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
US7186864B2
(en)
|
2002-05-29 |
2007-03-06 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
US7074806B2
(en)
*
|
2002-06-06 |
2006-07-11 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
GB2389530B
(en)
|
2002-06-14 |
2007-01-10 |
Cipla Ltd |
Pharmaceutical compositions
|
|
WO2004005229A1
(en)
*
|
2002-07-08 |
2004-01-15 |
Pfizer Products Inc. |
Modulators of the glucocorticoid receptor
|
|
CA2496175A1
(en)
|
2002-08-21 |
2004-03-04 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
|
|
NZ538932A
(en)
*
|
2002-08-29 |
2007-04-27 |
Boehringer Ingelheim Pharma |
3-(sulfonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative disease
|
|
US20040220153A1
(en)
*
|
2002-09-24 |
2004-11-04 |
Jost-Price Edward Roydon |
Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
|
|
BR0314872A
(pt)
*
|
2002-10-18 |
2005-08-02 |
Pfizer Prod Inc |
Ligandos do receptor canabinóide e usos dos mesmos
|
|
US20060052354A1
(en)
*
|
2002-11-05 |
2006-03-09 |
Corcept Therapeutics, Inc. |
Methods for treating migraine
|
|
CA2504751C
(en)
*
|
2002-11-05 |
2013-02-05 |
Corcept Therapeutics, Inc. |
Methods for treating gastroesophageal reflux disease
|
|
EP1583745A1
(en)
|
2003-01-03 |
2005-10-12 |
Boehringer Ingelheim Pharmaceuticals Inc. |
1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
|
|
TW200503994A
(en)
*
|
2003-01-24 |
2005-02-01 |
Novartis Ag |
Organic compounds
|
|
US20050020550A1
(en)
*
|
2003-04-29 |
2005-01-27 |
Morris David J. |
Selective testicular 11beta-HSD inhibitors and methods of use thereof
|
|
US8097606B2
(en)
|
2003-07-23 |
2012-01-17 |
Corcept Therapeutics, Inc. |
Antiglucocorticoids for the treatment of catatonia
|
|
NZ527142A
(en)
*
|
2003-07-23 |
2006-03-31 |
Douglas Pharmaceuticals Ltd |
A stable suspension formulation
|
|
UY28526A1
(es)
|
2003-09-24 |
2005-04-29 |
Boehringer Ingelheim Pharma |
Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
|
|
TW200517114A
(en)
|
2003-10-15 |
2005-06-01 |
Combinatorx Inc |
Methods and reagents for the treatment of immunoinflammatory disorders
|
|
JP4468369B2
(ja)
|
2003-10-16 |
2010-05-26 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
ある種のトリフルオロメチル置換アルコールの立体選択的合成
|
|
EP1685110A1
(en)
*
|
2003-11-13 |
2006-08-02 |
Pfizer Products Inc. |
Octahydrophenanthrene hydrazide derivatives useful as glucocorticoid receptor modulators
|
|
JP2007512337A
(ja)
|
2003-11-21 |
2007-05-17 |
コンビナトアールエックス インコーポレーティッド |
炎症性障害の治療のための方法および試薬
|
|
US7253283B2
(en)
|
2004-01-16 |
2007-08-07 |
Bristol-Myers Squibb Company |
Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
|
|
US7795272B2
(en)
*
|
2004-03-13 |
2010-09-14 |
Boehringer Ingelheim Pharmaceutical, Inc. |
Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
|
|
US20050261292A1
(en)
*
|
2004-05-19 |
2005-11-24 |
Solvay Pharmaceuticals Gmbh |
Pharmaceutical composition containing N-sulfamoyl-N'-arylpiperazines for the treatment or inhibition of obesity and related conditions
|
|
US20090156565A1
(en)
*
|
2004-12-03 |
2009-06-18 |
The Children's Hospital Of Philadelphia |
Composition and use thereof in enhancing a therapeutic effect of an antiepileptic drug
|
|
PE20060776A1
(es)
|
2004-12-27 |
2006-09-26 |
Boehringer Ingelheim Pharma |
Mimeticos de glucocorticoides, metodos para prepararlos y composiciones farmaceuticas
|
|
US8067433B2
(en)
|
2005-11-09 |
2011-11-29 |
Zalicus Inc. |
Methods, compositions, and kits for the treatment of ophthalmic disorders
|
|
US7640389B2
(en)
*
|
2006-02-28 |
2009-12-29 |
Freescale Semiconductor, Inc. |
Non-volatile memory having a multiple block erase mode and method therefor
|
|
US20080045475A1
(en)
*
|
2006-08-20 |
2008-02-21 |
Phillip Edward Littmann |
Elemental cellular therapy is a genetic, cellular and disease-modifying therapy which enhances the systemic conduct of genetic and cellular transmethylation activity resulting in enhancement of concerted genetic and cellular metabolic, physiologic and homeostatic processes
|
|
MX2009005264A
(es)
*
|
2006-12-06 |
2009-05-28 |
Boehringer Ingelheim Int |
Mimeticos de glucocorticoides, metodos para su fabricacion, composiciones farmaceuticas y usos de los mismos.
|
|
DK2114970T3
(da)
|
2007-02-02 |
2011-09-19 |
Pfizer Prod Inc |
Tricykliske forbindelser og deres anvendelse som glucocorticoidreceptormodulatorer
|
|
UZ4378C
(en)
*
|
2007-02-02 |
2011-07-29 |
Pfizer Prod Inc |
Tricyclic compounds and their use as glucocorticoid receptor modulators
|
|
DK2300472T3
(da)
*
|
2008-06-06 |
2012-04-10 |
Boehringer Ingelheim Int |
Glucocorticoidmimetika, fremgangsmåder til disses fremstilling, farmaceutiske sammensætninger samt anvendelser deraf
|
|
BRPI0917212A2
(pt)
|
2008-07-28 |
2015-11-10 |
Pfizer |
compostos de fenantrenona, seus usos na preparação de composições, e composições compreendendo os referidos compostos
|
|
US20100092479A1
(en)
*
|
2008-08-18 |
2010-04-15 |
Combinatorx (Singapore) Pte. Ltd. |
Compositions and methods for treatment of viral diseases
|
|
CN101338200B
(zh)
*
|
2008-08-20 |
2011-08-17 |
石家庄国大工业有限公司 |
一种tn型液晶材料的混合物
|
|
ES2745628T3
(es)
|
2008-11-07 |
2020-03-03 |
Univ Sheffield |
Medicamento y método de diagnóstico
|
|
US20120220590A1
(en)
|
2009-07-31 |
2012-08-30 |
Thombare Pravin S |
Novel compounds as modulators of glucocorticoid receptors
|
|
CN102480964B
(zh)
|
2009-08-31 |
2015-07-08 |
默沙东公司 |
吡喃基芳基甲基苯并喹唑啉酮m1受体正向别构调节剂
|
|
CN103180288B
(zh)
*
|
2010-10-27 |
2015-03-25 |
希格马托制药工业公司 |
具有生物学特性的二萜类衍生物
|
|
BR112013033777A2
(pt)
*
|
2011-03-15 |
2016-09-13 |
Abbvie Inc |
moduladores de receptor de hormônio nuclear
|
|
WO2013041599A1
(en)
*
|
2011-09-21 |
2013-03-28 |
Givaudan Sa |
Pyridine derivates and their use as umami tastants
|
|
TW201422590A
(zh)
|
2012-09-07 |
2014-06-16 |
Abbvie Inc |
雜環核激素受體調節劑
|
|
EP2935284A4
(en)
|
2012-12-21 |
2016-04-27 |
Abbvie Inc |
HETEROCYCLIC MODULATORS OF HORMONE NUCLEAR RECEPTORS
|
|
BR112015021990A2
(pt)
*
|
2013-03-14 |
2017-07-18 |
Bristol Myers Squibb Co |
moduladores de gpr120 de ácido biciclo [2.2.1]
|
|
CZ305733B6
(cs)
*
|
2014-08-26 |
2016-02-24 |
Ústav organické chemie a biochemie AV ČR, v.v.i. |
Amfifilní sloučeniny s neuroprotektivními účinky
|
|
SK592017A3
(sk)
*
|
2017-07-04 |
2019-01-08 |
Saneca Pharmaceuticals A. S. |
Spôsob prípravy morfínanových zlúčenín
|
|
EP3821220B1
(en)
|
2018-08-22 |
2024-11-13 |
University of Utah Research Foundation |
Force and torque sensor for prosthetic and orthopedic devices
|
|
US12070398B2
(en)
|
2018-08-28 |
2024-08-27 |
University Of Utah Research Foundation |
Variable transmission for assistive prosthesis device
|
|
JP7516394B2
(ja)
|
2019-01-22 |
2024-07-16 |
アクリベス ビオメディカル ゲーエムベーハー |
皮膚創傷治癒不全を治療するための選択的グルココルチコイド受容体モジュレーター
|
|
AU2020239920A1
(en)
*
|
2019-03-18 |
2021-11-04 |
Arnold L. Newman |
Method of improving insulin sensitivity
|
|
US12048668B2
(en)
|
2020-03-20 |
2024-07-30 |
The University Of Utah Research Foundation |
Self-aligning mechanisms in passive and powered exoskeletons
|
|
WO2022232025A1
(en)
*
|
2021-04-26 |
2022-11-03 |
Alkermes, Inc. |
Substituted amide macrocyclic compounds with orexin-2 receptor agonist activity
|